Global Blood Therapeutics (GBT) Tops Q2 EPS by 7c
Tweet
Share
E-mail
Get Alerts GBT Hot Sheet
Price: $68.49 --0%
Financial Fact:
Cost of Goods Sold: 17.93M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Cost of Goods Sold: 17.93M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Global Blood Therapeutics (NASDAQ: GBT) reported Q2 EPS of ($1.12), $0.07 better than the analyst estimate of ($1.19). Revenue for the quarter came in at $47.6 million versus the consensus estimate of $43.84 million.
For earnings history and earnings-related data on Global Blood Therapeutics (GBT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Reading (RDI) Tops Q2 EPS by 4c
- Movano (MOVE) Misses Q2 EPS by 195c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
